Description
Bio-Rad Laboratories: Expanding In Digital PCR To Strengthen Presence & Advance Molecular Diagnostics!
Bio-Rad Laboratories recently announced its financial results for the fourth quarter and the full fiscal year 2024, revealing both achievements and challenges. The company reported net sales of approximately $668 million in the fourth quarter, representing a decline of 2% on a reported basis compared to the same period last year. This decrease was largely attributed to a shorter turnaround in the Life Science segment and fluctuations in the biopharma market, notably in China, which still reflected a market downturn.
Our Report Structure:
⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures
Want unlimited access to our reports? Purchase our $99 annual subscription!
